Published in Ther Clin Risk Manag on May 27, 2013
Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapy. Ther Clin Risk Manag (2015) 0.90
Pharmacokinetic drug-drug interactions between 1,4-dihydropyridine calcium channel blockers and statins: factors determining interaction strength and relevant clinical risk management. Ther Clin Risk Manag (2013) 0.82
The association between gastric acid inhibitors and delirium in geriatric inpatients: implications for clinical practice and research. Clin Interv Aging (2016) 0.75
Effect of esomeprazole on the oral absorption of dasatinib in a patient with Philadelphia-positive acute lymphoblastic leukemia. Br J Clin Pharmacol (2016) 0.75
Potential therapeutic hazards due to drug-drug interaction between topically and systemically coadministered medications. Ther Clin Risk Manag (2013) 0.75
The compelling case for therapeutic drug monitoring of mycophenolate mofetil therapy. Pediatr Nephrol (2016) 0.75
Therapeutic Risk and Benefits of Concomitantly Using Herbal Medicines and Conventional Medicines: From the Perspectives of Evidence Based on Randomized Controlled Trials and Clinical Risk Management. Evid Based Complement Alternat Med (2017) 0.75
Opioid analgesics-related pharmacokinetic drug interactions: from the perspectives of evidence based on randomized controlled trials and clinical risk management. J Pain Res (2017) 0.75
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ (2009) 34.99
Clopidogrel with or without omeprazole in coronary artery disease. N Engl J Med (2010) 7.39
Relative activation of human pregnane X receptor versus constitutive androstane receptor defines distinct classes of CYP2B6 and CYP3A4 inducers. J Pharmacol Exp Ther (2006) 2.23
Drug-drug interaction between clopidogrel and the proton pump inhibitors. Ann Pharmacother (2009) 1.92
St John's wort induces both cytochrome P450 3A4-catalyzed sulfoxidation and 2C19-dependent hydroxylation of omeprazole. Clin Pharmacol Ther (2004) 1.79
Drug interactions with new and investigational antiretrovirals. Clin Pharmacokinet (2009) 1.77
A traditional herbal medicine enhances bilirubin clearance by activating the nuclear receptor CAR. J Clin Invest (2004) 1.64
Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein. Naunyn Schmiedebergs Arch Pharmacol (2001) 1.57
Omeprazole-associated digoxin toxicity. South Med J (2007) 1.49
Posaconazole exposure-response relationship: evaluating the utility of therapeutic drug monitoring. Antimicrob Agents Chemother (2012) 1.39
Pharmacokinetic drug interaction profiles of proton pump inhibitors. Drug Saf (2006) 1.32
Drug-related problems in hospitalized patients on polypharmacy: the influence of age and gender. Ther Clin Risk Manag (2005) 1.29
Omeprazole inhibits oxidative drug metabolism. Studies with diazepam and phenytoin in vivo and 7-ethoxycoumarin in vitro. Gastroenterology (1985) 1.29
Identification of constitutive androstane receptor and glucocorticoid receptor binding sites in the CYP2C19 promoter. Mol Pharmacol (2003) 1.25
Pharmacokinetic profile and tolerability of indinavir-ritonavir combinations in healthy volunteers. Antimicrob Agents Chemother (2001) 1.24
Clopidogrel-drug interactions. J Am Coll Cardiol (2011) 1.23
Proton pump inhibitors and their drug interactions: an evidence-based approach. Eur J Gastroenterol Hepatol (2001) 1.17
Potential drug-drug interactions within Veterans Affairs medical centers. Am J Health Syst Pharm (2007) 1.11
A randomized, 2-period, crossover design study to assess the effects of dexlansoprazole, lansoprazole, esomeprazole, and omeprazole on the steady-state pharmacokinetics and pharmacodynamics of clopidogrel in healthy volunteers. J Am Coll Cardiol (2012) 1.08
Evaluation of six proton pump inhibitors as inhibitors of various human cytochromes P450: focus on cytochrome P450 2C19. Drug Metab Dispos (2012) 1.08
Effect of a cola beverage on the bioavailability of itraconazole in the presence of H2 blockers. J Clin Pharmacol (1997) 1.04
Pharmacogenetics and herb-drug interactions: experience with Ginkgo biloba and omeprazole. Pharmacogenetics (2004) 1.02
Carbamazepine treatment induces the CYP3A4 catalysed sulphoxidation of omeprazole, but has no or less effect on hydroxylation via CYP2C19. Br J Clin Pharmacol (1997) 1.02
Comparison of the interaction potential of a new proton pump inhibitor, E3810, versus omeprazole with diazepam in extensive and poor metabolizers of S-mephenytoin 4'-hydroxylation. Clin Pharmacol Ther (1995) 1.01
Rilpivirine: a new non-nucleoside reverse transcriptase inhibitor. J Antimicrob Chemother (2012) 1.01
Accumulating evidence for a drug-drug interaction between methotrexate and proton pump inhibitors. Oncologist (2012) 1.00
Human CYP2C19 is a major omeprazole 5-hydroxylase, as demonstrated with recombinant cytochrome P450 enzymes. Drug Metab Dispos (1996) 1.00
Polypharmacy in elderly patients at discharge from the acute care hospital. Ther Clin Risk Manag (2007) 0.99
Omeprazole significantly reduces posaconazole serum trough level. Clin Infect Dis (2009) 0.99
Effect of omeprazole on the pharmacokinetics of itraconazole. Eur J Clin Pharmacol (1998) 0.95
Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy. Ann Pharmacother (2013) 0.93
Impact of intestinal CYP2C19 genotypes on the interaction between tacrolimus and omeprazole, but not lansoprazole, in adult living-donor liver transplant patients. Drug Metab Dispos (2009) 0.92
Effect of low-dose omeprazole (20 mg daily) on the pharmacokinetics of multiple-dose atazanavir with ritonavir in healthy subjects. J Clin Pharmacol (2010) 0.92
Esomeprazole compared with famotidine in the prevention of upper gastrointestinal bleeding in patients with acute coronary syndrome or myocardial infarction. Am J Gastroenterol (2011) 0.91
Potential interaction between methotrexate and omeprazole. Ann Pharmacother (2000) 0.91
Pantoprazole does not influence the antiplatelet effect of clopidogrel-a whole blood aggregometry study after coronary stenting. J Cardiovasc Pharmacol (2010) 0.91
Omeprazole reduces clozapine plasma concentrations. A case report. Pharmacopsychiatry (2003) 0.91
A review of rabeprazole in the treatment of acid-related diseases. Ther Clin Risk Manag (2007) 0.90
Specific and dose-dependent enzyme induction by omeprazole in human beings. Hepatology (1994) 0.90
Effect of Ginkgo biloba special extract EGb 761® on human cytochrome P450 activity: a cocktail interaction study in healthy volunteers. Eur J Clin Pharmacol (2011) 0.89
Lack of effect of Ginkgo biloba on voriconazole pharmacokinetics in Chinese volunteers identified as CYP2C19 poor and extensive metabolizers. Ann Pharmacother (2009) 0.88
Significant decrease in nelfinavir systemic exposure after omeprazole coadministration in healthy subjects. Pharmacotherapy (2008) 0.88
A randomized comparative study to determine the effect of omeprazole on the peak serum concentration of itraconazole oral solution. J Antimicrob Chemother (2003) 0.88
Omeprazole induces gastric permeability to digoxin. Dig Dis Sci (2009) 0.87
Clinical outcomes and management of mechanism-based inhibition of cytochrome P450 3A4. Ther Clin Risk Manag (2005) 0.87
Interaction between methotrexate and omeprazole in an adolescent with leukemia: a case report. Pharm World Sci (2008) 0.87
Inducibility of CYP1A2 by omeprazole in vivo related to the genetic polymorphism of CYP1A2. Br J Clin Pharmacol (2002) 0.87
Effect of omeprazole on the pharmacokinetics of sustained-release carbamazepine in healthy male volunteers. Methods Find Exp Clin Pharmacol (2001) 0.86
Drug-drug interaction profiles of proton pump inhibitors. Clin Pharmacokinet (2010) 0.86
Drug interactions between HIV protease inhibitors and acid-reducing agents. Clin Pharmacokinet (2008) 0.86
Evaluation of an alternative posaconazole prophylaxis regimen in haematological malignancy patients receiving concomitant stress ulcer prophylaxis. Int J Antimicrob Agents (2012) 0.86
Retrospective evaluation of the effect of omeprazole on clozapine metabolism. Pharm World Sci (2004) 0.85
Clopidogrel and proton pump inhibitors--where do we stand in 2012? World J Gastroenterol (2012) 0.85
Induction of CYP2C19 and CYP3A activity following repeated administration of efavirenz in healthy volunteers. Clin Pharmacol Ther (2012) 0.85
Increased clozapine plasma concentrations and side effects induced by smoking cessation in 2 CYP1A2 genotyped patients. Ther Drug Monit (2005) 0.85
Lack of pharmacokinetic interaction of pantoprazole with diazepam in man. Br J Clin Pharmacol (1996) 0.85
Identification of drugs inhibiting the in vitro metabolism of tacrolimus by human liver microsomes. Br J Clin Pharmacol (1996) 0.84
Steady-state pharmacokinetics of once-daily fosamprenavir/ritonavir and atazanavir/ritonavir alone and in combination with 20 mg omeprazole in healthy volunteers. HIV Med (2007) 0.83
Influence of lansoprazole treatment on diazepam plasma concentrations. Clin Pharmacol Ther (1992) 0.82
Omeprazole impairs the absorption of mycophenolate mofetil but not of enteric-coated mycophenolate sodium in healthy volunteers. J Clin Pharmacol (2011) 0.82
Pharmacokinetic interaction between the proton pump inhibitor omeprazole and the HIV protease inhibitor indinavir. AIDS (1998) 0.82
Effect of esomeprazole versus famotidine on platelet inhibition by clopidogrel: a double-blind, randomized trial. Am Heart J (2011) 0.82
Interethnic difference in omeprazole's inhibition of diazepam metabolism. Clin Pharmacol Ther (1995) 0.81
Herbal medicine yin zhi huang induces CYP3A4-mediated sulfoxidation and CYP2C19-dependent hydroxylation of omeprazole. Acta Pharmacol Sin (2007) 0.81
Comparison of P-glycoprotein-mediated drug-digoxin interactions in Caco-2 with human and rodent intestine: relevance to in vivo prediction. Eur J Pharm Sci (2005) 0.81
Effects of Ginkgo biloba extracts on diazepam metabolism: a pharmacokinetic study in healthy Chinese male subjects. Eur J Clin Pharmacol (2010) 0.81
Pharmacokinetics of saquinavir co-administered with cimetidine. J Antimicrob Chemother (2002) 0.80
Effect of omeprazole on the plasma concentrations of indinavir when administered alone and in combination with ritonavir. Am J Health Syst Pharm (2008) 0.80
Suboptimal response to ferrous sulfate in iron-deficient patients taking omeprazole. Am J Ther (2012) 0.80
Absence of influence of concomitant administration of rabeprazole on the pharmacokinetics of tacrolimus in adult living-donor liver transplant patients: a case-control study. Drug Metab Pharmacokinet (2009) 0.79
Distinct effects of omeprazole and rabeprazole on the tacrolimus blood concentration in a kidney transplant recipient. Drug Metab Pharmacokinet (2007) 0.79
Rabeprazole for the treatment of acid-related disorders. Expert Rev Gastroenterol Hepatol (2012) 0.79
Interaction between tacrolimus and lansoprazole, but not rabeprazole in living-donor liver transplant patients with defects of CYP2C19 and CYP3A5. Drug Metab Pharmacokinet (2008) 0.79
Proton pump inhibitor co-medication reduces active drug exposure in heart transplant recipients receiving mycophenolate mofetil. Transplant Proc (2010) 0.79
Impact of ritonavir, atazanavir and their combination on the CYP3A4 induction potential of efavirenz in primary human hepatocytes. Drug Metab Lett (2010) 0.78
Pantoprazole lacks induction of CYP1A2 activity in man. Int J Clin Pharmacol Ther (1999) 0.78
Lack of interaction between pantoprazole and digoxin at therapeutic doses in man. Int J Clin Pharmacol Ther (1996) 0.77
Drug-drug interaction of rabeprazole and clopidogrel in healthy Chinese volunteers. Eur J Clin Pharmacol (2012) 0.77
Spaced administration of PA32540 and clopidogrel results in greater platelet inhibition than synchronous administration of enteric-coated aspirin and enteric-coated omeprazole and clopidogrel. Am Heart J (2012) 0.77
Clinical implications of the nelfinavir-proton pump inhibitor drug interaction in patients with human immunodeficiency virus. Pharmacotherapy (2011) 0.77
Ranitidine does not alter single-dose carbamazepine pharmacokinetics in healthy adults. Drug Intell Clin Pharm (1985) 0.76
The role of proton pump inhibitors on early mycophenolic acid exposure in kidney transplantation: evidence from the CLEAR study. Ther Drug Monit (2011) 0.76
Suspicion of drug-drug interaction between high-dose methotrexate and proton pump inhibitors: a case report - should the practice be changed? Chemotherapy (2011) 0.76
Pantoprazole does not interact with the pharmacokinetics of carbamazepine. Int J Clin Pharmacol Ther (1998) 0.76
Diminished mycophenolic acid exposure caused by omeprazole may be clinically relevant in the first week posttransplantation. Ther Drug Monit (2012) 0.76
The effect of pantoprazole on tacrolimus and cyclosporin A blood concentration in transplant recipients. Eur J Clin Pharmacol (2000) 0.76
A clinically significant interaction between tacrolimus and multiple proton pump inhibitors in a kidney transplant recipient. Pediatr Transplant (2011) 0.76
Additional discussions regarding the altered metabolism and transport of omeprazole after long-term use of St John's wort. Clin Pharmacol Ther (2005) 0.76
Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation. Nat Genet (2013) 3.87
Inhibition of lymphangiogenesis and lymphatic drainage via vascular endothelial growth factor receptor 3 blockade increases the severity of inflammation in a mouse model of chronic inflammatory arthritis. Arthritis Rheum (2009) 1.54
Bispecific small molecule-antibody conjugate targeting prostate cancer. Proc Natl Acad Sci U S A (2013) 1.52
SOAPfuse: an algorithm for identifying fusion transcripts from paired-end RNA-Seq data. Genome Biol (2013) 1.47
Functional imaging of cerebrovascular activities in small animals using high-resolution photoacoustic tomography. Med Phys (2007) 1.47
Ubiquitin ligase Smurf1 mediates tumor necrosis factor-induced systemic bone loss by promoting proteasomal degradation of bone morphogenetic signaling proteins. J Biol Chem (2008) 1.41
Human pregnane X receptor and resistance to chemotherapy in prostate cancer. Cancer Res (2007) 1.35
Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells. Int J Pharm (2007) 1.35
Coverage evaluation of universal bacterial primers using the metagenomic datasets. BMC Microbiol (2012) 1.34
Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids Surf B Biointerfaces (2005) 1.25
VEGF-C, a lymphatic growth factor, is a RANKL target gene in osteoclasts that enhances osteoclastic bone resorption through an autocrine mechanism. J Biol Chem (2008) 1.19
Preparation of two sets of 5,6,7-trioxygenated dihydroflavonol derivatives as free radical scavengers and neuronal cell protectors to oxidative damage. Bioorg Med Chem (2009) 1.16
CD23(+)/CD21(hi) B-cell translocation and ipsilateral lymph node collapse is associated with asymmetric arthritic flare in TNF-Tg mice. Arthritis Res Ther (2011) 1.15
Intervention for improving the appropriateness of physician orders for oral medications in geriatric VIP patients during the journey to JCI accreditation. Ther Clin Risk Manag (2013) 1.14
A novel chitosan oligosaccharide-stearic acid micelles for gene delivery: properties and in vitro transfection studies. Int J Pharm (2006) 1.14
A pragmatic approach to β-lactam use in patients with penicillin allergy. Allergy Asthma Proc (2013) 1.12
Shell cross-linked stearic acid grafted chitosan oligosaccharide self-aggregated micelles for controlled release of paclitaxel. Colloids Surf B Biointerfaces (2006) 1.08
A continuous observation of the degenerative process in the intervertebral disc of Smad3 gene knock-out mice. Spine (Phila Pa 1976) (2009) 1.04
Studies on oral absorption of stearic acid SLN by a novel fluorometric method. Colloids Surf B Biointerfaces (2007) 1.04
Nuclear receptors PXR and CAR: implications for drug metabolism regulation, pharmacogenomics and beyond. Expert Opin Drug Metab Toxicol (2013) 1.01
Preparation and characteristics of monostearin nanostructured lipid carriers. Int J Pharm (2006) 1.01
Medium optimization for phenazine-1-carboxylic acid production by a gacA qscR double mutant of Pseudomonas sp. M18 using response surface methodology. Bioresour Technol (2010) 1.01
Osthole stimulates osteoblast differentiation and bone formation by activation of beta-catenin-BMP signaling. J Bone Miner Res (2010) 1.00
PXR-mediated transcriptional activation of CYP3A4 by cryptotanshinone and tanshinone IIA. Chem Biol Interact (2008) 0.98
Drug-induced liver injury in hospitalized patients with notably elevated alanine aminotransferase. World J Gastroenterol (2012) 0.97
Permeation of astilbin and taxifolin in Caco-2 cell and their effects on the P-gp. Int J Pharm (2009) 0.95
Discrimination analysis of mass spectrometry proteomics for ovarian cancer detection. Acta Pharmacol Sin (2008) 0.94
Maternal embryonic leucine zipper kinase enhances gastric cancer progression via the FAK/Paxillin pathway. Mol Cancer (2014) 0.94
Identification of novel pregnane X receptor activators from traditional Chinese medicines. J Ethnopharmacol (2011) 0.94
Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification. Colloids Surf B Biointerfaces (2007) 0.94
Cytotoxic, cytoprotective and antioxidant effects of isolated phenolic compounds from fresh ginger. Fitoterapia (2012) 0.94
Metabolomics study on quality control and discrimination of three curcuma species based on gas chromatograph-mass spectrometry. Phytochem Anal (2011) 0.93
In-depth proteomic analysis of the human sperm reveals complex protein compositions. J Proteomics (2012) 0.93
Lentivirus-mediated inhibition of USP39 suppresses the growth of breast cancer cells in vitro. Oncol Rep (2013) 0.92
Hepatocyte growth factor activates tumor stromal fibroblasts to promote tumorigenesis in gastric cancer. Cancer Lett (2013) 0.92
Enantiomeric separation of 2-arylpropionic acid nonsteroidal anti-inflammatory drugs by HPLC with hydroxypropyl-beta-cyclodextrin as chiral mobile phase additive. Biomed Chromatogr (2010) 0.89
Intestinal absorption of luteolin from peanut hull extract is more efficient than that from individual pure luteolin. J Agric Food Chem (2007) 0.89
Quantitative determination of rosuvastatin in human plasma by liquid chromatography with electrospray ionization tandem mass spectrometry. Rapid Commun Mass Spectrom (2006) 0.89
Carboxyl terminus of Hsp70-interacting protein (CHIP) contributes to human glioma oncogenesis. Cancer Sci (2011) 0.89
Glucuronidation of flavonoids by recombinant UGT1A3 and UGT1A9. Biochem Pharmacol (2008) 0.89
Distribution and metabolism of gastrodin in rat brain. J Pharm Biomed Anal (2007) 0.89
Production of reactive oxygen species, impairment of photosynthetic function and dynamic changes in mitochondria are early events in cadmium-induced cell death in Arabidopsis thaliana. Biol Cell (2009) 0.88
Cervical intervertebral disc degeneration induced by unbalanced dynamic and static forces: a novel in vivo rat model. Spine (Phila Pa 1976) (2006) 0.88
Estrogen sulfotransferase inhibits adipocyte differentiation. Mol Endocrinol (2011) 0.88
Influence of various polymorphic variants of cytochrome P450 oxidoreductase (POR) on drug metabolic activity of CYP3A4 and CYP2B6. PLoS One (2012) 0.88
HPLC analysis of para-aminosalicylic acid and its metabolite in plasma, cerebrospinal fluid and brain tissues. J Pharm Biomed Anal (2010) 0.87
Investigation on modulation of human P-gp by multiple doses of Radix Astragali extract granules using fexofenadine as a phenotyping probe. J Ethnopharmacol (2013) 0.86
Simvastatin pharmacokinetics in healthy Chinese subjects and its relations with CYP2C9, CYP3A5, ABCB1, ABCG2 and SLCO1B1 polymorphisms. Pharmazie (2013) 0.86
CYP2C9*3(1075A > C), ABCB1 and SLCO1B1 genetic polymorphisms and gender are determinants of inter-subject variability in pitavastatin pharmacokinetics. Pharmazie (2013) 0.86
Determination of gemcitabine and its metabolite in human plasma using high-pressure liquid chromatography coupled with a diode array detector. Acta Pharmacol Sin (2004) 0.85
Absorption and excretion of luteolin and apigenin in rats after oral administration of Chrysanthemum morifolium extract. J Agric Food Chem (2007) 0.85
Enantioselective plasma protein binding of propafenone: mechanism, drug interaction, and species difference. Chirality (2009) 0.85
Design, synthesis, and examination of neuron protective properties of alkenylated and amidated dehydro-silybin derivatives. J Med Chem (2009) 0.85
Detection of foreign body using fast thermoacoustic tomography with a multielement linear transducer array. Appl Phys Lett (2007) 0.85
Nuclear localization of annexin A1 correlates with advanced disease and peritoneal dissemination in patients with gastric carcinoma. Anat Rec (Hoboken) (2010) 0.85
Safe medication use based on knowledge of information about contraindications concerning cross allergy and comprehensive clinical intervention. Ther Clin Risk Manag (2013) 0.85
Rational prescription of drugs within similar therapeutic or structural class for gastrointestinal disease treatment: drug metabolism and its related interactions. World J Gastroenterol (2007) 0.85
Stereoselective propranolol metabolism in two drug induced rat hepatic microsomes. World J Gastroenterol (2000) 0.85
Characterizing the effect of UDP-glucuronosyltransferase (UGT) 2B7 and UGT1A9 genetic polymorphisms on enantioselective glucuronidation of flurbiprofen. Biochem Pharmacol (2011) 0.85
Prolonged upright posture induces degenerative changes in intervertebral discs in rat lumbar spine. Spine (Phila Pa 1976) (2008) 0.84
Oleanolic acid exerts an osteoprotective effect in ovariectomy-induced osteoporotic rats and stimulates the osteoblastic differentiation of bone mesenchymal stem cells in vitro. Menopause (2012) 0.84
Targeting human C-type lectin-like molecule-1 (CLL1) with a bispecific antibody for immunotherapy of acute myeloid leukemia. Angew Chem Int Ed Engl (2014) 0.84
Crystal structure and nucleotide selectivity of human IFIT5/ISG58. Cell Res (2013) 0.84
The two enantiomers of tetrahydropalmatine are inhibitors of P-gp, but not inhibitors of MRP1 or BCRP. Xenobiotica (2012) 0.84
Role of catechol-O-methyltransferase in the disposition of luteolin in rats. Drug Metab Dispos (2011) 0.84
Scanning of novel cancer/testis proteins by human testis proteomic analysis. Proteomics (2013) 0.83
Identify changes of brain regional homogeneity in bipolar disorder and unipolar depression using resting-state FMRI. PLoS One (2013) 0.83
Phenazine-1-carboxylic acid production in a chromosomally non-scar triple-deleted mutant Pseudomonas aeruginosa using statistical experimental designs to optimize yield. Appl Microbiol Biotechnol (2013) 0.83
Carboxyl-glucuronidation of mitiglinide by human UDP-glucuronosyltransferases. Biochem Pharmacol (2007) 0.83
Trienamine catalysis with 2,4-dienones: development and application in asymmetric Diels-Alder reactions. Angew Chem Int Ed Engl (2012) 0.83
Preparation of C-23 esterified silybin derivatives and evaluation of their lipid peroxidation inhibitory and DNA protective properties. Bioorg Med Chem (2009) 0.83
Solid lipid nanoparticles prepared by solvent diffusion method in a nanoreactor system. Colloids Surf B Biointerfaces (2007) 0.83
Muscone protects vertebral end-plate degeneration by antiinflammatory property. Clin Orthop Relat Res (2009) 0.83
Determination of enantiomeric impurity in besifloxacin hydrochloride by chiral high-performance liquid chromatography with precolumn derivatization. Chirality (2012) 0.82
Simultaneous strain and temperature measurement by cascading few-mode fiber and single-mode fiber long-period fiber gratings. Appl Opt (2014) 0.82
Application of a liquid chromatography-tandem mass spectrometry method to the pharmacokinetics, tissue distribution and excretion studies of Dactylicapnos scandens in rats. J Pharm Biomed Anal (2012) 0.82
The expression of osteoprotegerin is required for maintaining the intervertebral disc endplate of aged mice. Bone (2011) 0.82
Stereoselective binding of chiral drugs to plasma proteins. Acta Pharmacol Sin (2013) 0.82
Involvement of annexin A1 in multidrug resistance of K562/ADR cells identified by the proteomic study. OMICS (2009) 0.82
Effects of iron oxide nanoparticle labeling on human endothelial cells. Cell Transplant (2012) 0.82
Transport characteristics of zolmitriptan in a human intestinal epithelial cell line Caco-2. J Pharm Pharmacol (2007) 0.81
[Research progress of zebrafish used in drug metabolism]. Yao Xue Xue Bao (2011) 0.81
Involvement of AP-1 and NF-κB in the up-regulation of P-gp in vinblastine resistant Caco-2 cells. Drug Metab Pharmacokinet (2013) 0.81
The exposure of luteolin is much lower than that of apigenin in oral administration of Flos Chrysanthemi extract to rats. Drug Metab Pharmacokinet (2011) 0.81
Flotillin-2 is an acrosome-related protein involved in mouse spermiogenesis. J Biomed Res (2012) 0.81
Appropriateness of administration of nasogastric medication and preliminary intervention. Ther Clin Risk Manag (2012) 0.81
Microwave-induced thermoacoustic scanning CT for high-contrast and noninvasive breast cancer imaging. Med Phys (2008) 0.81
An overview of ABC and SLC drug transporter gene regulation. Curr Drug Metab (2013) 0.81
Effects of stereochemical aspects on drug interaction in pharmacokinetics. Acta Pharmacol Sin (2002) 0.81
Comparative transcriptomic analysis of the heat stress response in the filamentous fungus Metarhizium anisopliae using RNA-Seq. Appl Microbiol Biotechnol (2014) 0.81
Stereoselective transport and uptake of propranolol across human intestinal Caco-2 cell monolayers. Chirality (2010) 0.80
Expression of proton-coupled oligopeptide transporter (POTs) in prostate of mice and patients with benign prostatic hyperplasia (BPH) and prostate cancer (PCa). Prostate (2012) 0.80
Roles of UDP-glucuronosyltransferases in phytochemical metabolism of herbal medicines and the associated herb-drug interactions. Curr Drug Metab (2012) 0.80
Isoform-selective inhibition of chrysin towards human cytochrome P450 1A2. Kinetics analysis, molecular docking, and molecular dynamics simulations. Bioorg Med Chem Lett (2010) 0.80
Pharmacokinetics of Gastrodin in rat plasma and CSF after i.n. and i.v. Int J Pharm (2007) 0.80
Analysis of flurbiprofen, ketoprofen and etodolac enantiomers by pre-column derivatization RP-HPLC and application to drug-protein binding in human plasma. J Pharm Biomed Anal (2008) 0.80
Simultaneous determination of quercetin, kaempferol and isorhamnetin accumulated human breast cancer cells, by high-performance liquid chromatography. J Pharm Biomed Anal (2005) 0.80
ABCB1 gene polymorphisms, ABCB1 haplotypes and ABCG2 c.421c > A are determinants of inter-subject variability in rosuvastatin pharmacokinetics. Pharmazie (2013) 0.80